Back

Circulating beta-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Emerging insights in acute coronary syndrome: biomarkers, non-traditional risk factors, and clinical outcomes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yining Dai

Guangdong Provincial People's Hospital, Guangzhou (China)

8 More presentations in this session

Presentation thumbnail
Unique regional risk profiles and cardiovascular outcomes of patients with acute coronary syndrome in the absence of standard modifiable risk factors: a systematic review and meta-analysis
Doctor V. Vijay Anand (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Comparing the ability of GRACE 2.0 and GRACE 3 scores for predicting in-hospital mortality in patients with and without diabetes.
Doctor P. Chrysostomou (Bedford, GB)
Abstract Slides Video
Presentation thumbnail
Association of risk factors on mortality in ST-elevation myocardial infarction patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
Doctor R. Ipek (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of patients with acute coronary syndrome without standard metabolic cardiovascular risk factors
Mr S. Komaki (Miyazaki, JP)
Abstract Slides Video
Presentation thumbnail
Hair cortisol concentration, a biomarker of stress, is gradually increased in patients with acute myocardial infarction before the acute episode
Mr N. Kosmas (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging insights in acute coronary syndrome: biomarkers, non-traditional risk factors, and clinical outcomes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The added prognostic value of stress induced hyperglycemia to the GRACE risk score for the prediction of 1-year major adverse cardiovascular events in patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Impact of stress hyperglycemia ratio on periprocedural myocardial infarction in patients with NSTEMI
thumbnail
Congress Presentation
The gut-microbiome derived phenylacetylglutamine predicts adverse events in patients with acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources